These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1709511)
21. [A new treatment for vitiligo: topical Kandil therapy combined with oral P.A.B.A]. Pozo Carballido JL Actas Dermosifiliogr; 1978; 69(11-12):369-74. PubMed ID: 380273 [No Abstract] [Full Text] [Related]
22. [Adverse drug reactions on hair]. Gollnick H; Blume U; Orfanos CE Z Hautkr; 1990 Dec; 65(12):1128-34. PubMed ID: 2087842 [TBL] [Abstract][Full Text] [Related]
23. Lack of efficacy of polysorbate 60 in the treatment of male pattern baldness. Groveman HD; Ganiats T; Klauber MR Arch Intern Med; 1985 Aug; 145(8):1454-8. PubMed ID: 3896179 [TBL] [Abstract][Full Text] [Related]
24. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results. Price VH; Menefee E; Sanchez M; Kaufman KD J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383 [TBL] [Abstract][Full Text] [Related]
27. [Effect of minoxidil on hair growth in androgenic alopecia in women]. Brzezińska-Wcisło L Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572 [TBL] [Abstract][Full Text] [Related]
28. TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo. Hoffmann R Eur J Dermatol; 2001; 11(4):362-8. PubMed ID: 11399546 [TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Kaufman KD; Rotonda J; Shah AK; Meehan AG Eur J Dermatol; 2008; 18(4):400-6. PubMed ID: 18573712 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. Tosti A; Iorizzo M; Botta GL; Milani M J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039 [TBL] [Abstract][Full Text] [Related]
31. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356 [TBL] [Abstract][Full Text] [Related]
32. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. DeVillez RL; Jacobs JP; Szpunar CA; Warner ML Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy of specific chemotherapy combined with amben in newly diagnosed cases of destructive pulmonary tuberculosis]. Zamborg IuL Probl Tuberk; 1985; (7):24-7. PubMed ID: 3900995 [No Abstract] [Full Text] [Related]
34. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. Roberts JL; Fiedler V; Imperato-McGinley J; Whiting D; Olsen E; Shupack J; Stough D; DeVillez R; Rietschel R; Savin R; Bergfeld W; Swinehart J; Funicella T; Hordinsky M; Lowe N; Katz I; Lucky A; Drake L; Price VH; Weiss D; Whitmore E; Millikan L; Muller S; Gencheff C J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375 [TBL] [Abstract][Full Text] [Related]
35. [Effectiveness of the treatment plan for androgenetic alopecia]. Tsiskarishvili NV; Tsiskarishvili TsI Georgian Med News; 2007 Apr; (145):62-6. PubMed ID: 17525504 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of acne with a yeast preparation]. Weber G; Adamczyk A; Freytag S Fortschr Med; 1989 Sep; 107(26):563-6. PubMed ID: 2530145 [TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of anticancer therapy combined with p-aminobenzoic acid-N-xyloside]. Fujimoto S; Ishigami H; Okui K Gan To Kagaku Ryoho; 1982 Sep; 9(9):1574-9. PubMed ID: 6985199 [TBL] [Abstract][Full Text] [Related]
39. Nourkrin: objective and subjective effects and tolerability in persons with hair loss. Thom E J Int Med Res; 2006; 34(5):514-9. PubMed ID: 17133780 [TBL] [Abstract][Full Text] [Related]
40. [Changes in telogen rate, hair density, hair diameter and rate of growth in androgenetic alopecia of the male. Simultaneously a contribution to the significance of dysplastic hair]. Runne U; Martin H Hautarzt; 1986 Apr; 37(4):198-204. PubMed ID: 3700106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]